Related by context. All words. (Click for frequent words.) 68 MDR tuberculosis 68 candidemia 68 HCV infection 67 genital herpes infections 67 skeletal metastases 67 chronic HBV infection 67 chronic HBV 67 hepatitis C HCV 66 chronic HCV 66 Staphylococcus aureus infections 66 hepatitis C genotype 66 liver transplantations 66 ano genital warts 66 S. aureus infections 66 fluoroquinolone resistance 65 viral subtypes 65 micafungin 65 LTBI 65 staphylococcal infections 65 serotype #A 65 chlamydial infections 65 GIST tumors 64 renal cell carcinomas 64 nosocomial pneumonia 64 chronic HCV infection 64 Clostridium difficile infections 64 Chronic lymphocytic leukemia 64 S. aureus isolates 64 nonmelanoma skin cancers 64 invasive candidiasis 64 Chlamydia trachomatis 64 multidrug resistant 64 squamous cell lung cancer 64 P. falciparum malaria 64 radezolid 64 gastric cancers 64 Gleevec resistant 64 cSSSIs 64 N. gonorrhoeae 64 CMV disease 64 herpes zoster shingles 63 superficial bladder cancer 63 immunocompromised patients 63 cIAI 63 CMV infection 63 tigecycline 63 chronic hepatitis cirrhosis 63 NNRTI resistance 63 SCCHN 63 basal cell carcinoma BCC 63 chlamydial infection 63 bacteraemia 63 allogeneic HSCT 63 OHR/AVR# 63 malignant pleural mesothelioma 63 Velcade bortezomib 63 antibiotic resistant bacterial infections 63 HCV genotypes 63 EGFR mutations 63 Clostridium difficile infection 63 vWD 63 invasive fungal infection 63 Recombinant interferon alpha 63 alemtuzumab treated 63 HCV infected 63 simplex virus 63 latent TB infection 63 pediatric acute lymphoblastic 63 Pseudomonas aeruginosa infections 63 NOMID 62 asymptomatic carriers 62 T SPOT.TB test 62 chronic Hepatitis B 62 CYT# potent vascular disrupting 62 parasitic worm infections 62 K ras mutations 62 HBeAg negative 62 Salmonella typhi 62 virus HCV infection 62 carcinoid 62 systemic fungal infections 62 hepatitis C infection 62 relapsed MM 62 metastatic neuroendocrine tumors 62 H pylori 62 Chlamydia trachomatis infection 62 DEFLUX 62 hepatorenal syndrome 62 Candida infection 62 CTAP# Capsules 62 CCR5 receptor antagonist 62 poor metabolizers 62 leukemia ALL 62 de aths 62 osteosarcomas 62 gastric adenocarcinoma 62 CMV retinitis 62 colorectal cancer CRC 62 C. trachomatis 62 elvucitabine 62 familial ALS 62 latently infected 62 stem cell transplantations 62 nonsmall cell lung cancer 62 leukaemias 62 oral FTY# 62 differentiated thyroid 62 heterozygous FH 62 Tindamax R 62 cytomegalovirus infection 62 elevated triglyceride levels 62 iclaprim 62 TroVax ® 61 HER2 positive cancers 61 Genital herpes 61 adult chronic ITP 61 daptomycin 61 immunocompetent 61 pancreatic NET 61 vivax malaria 61 medullary thyroid cancer 61 MMP inhibitors 61 intravenous bisphosphonates 61 immunosuppressed patients 61 Multidrug resistant 61 mesotheliomas 61 heavily pretreated 61 basal cell nevus syndrome 61 Hepatocellular Carcinoma HCC 61 invasive fungal infections 61 tuberculin skin testing 61 genital ulcers 61 HAV infection 61 enterococcal 61 Ixiaro 61 sJIA 61 chronic hepatitis B. 61 H. pylori infections 61 genital ulcer disease 61 Renal Cell Carcinoma RCC 61 caspofungin 61 RSV infections 61 Squamous 61 riociguat 61 HIV HCV coinfected 61 liposomal amphotericin B 61 C. difficile infections 61 chlamydial 61 relapsing remitting MS RRMS 61 venous blood clots 61 neuroendocrine cancers 61 HBV infection 61 imatinib Gleevec 61 chronic hepatitis 61 clade B 61 Neisseria gonorrhoeae 61 renal tumors 61 Reverset 61 Trichomonas vaginalis 61 therapeutic regimens 61 invasive aspergillosis 61 follicular lymphomas 61 non metastatic osteosarcoma 61 CA MRSA infections 61 epithelial tumors 61 virological response 61 HBV infections 61 AA Amyloidosis 61 immunosuppressive therapies 61 acute rheumatic fever 61 macrolide resistance 61 candidiasis 61 malignant neoplasms 61 herpes zoster vaccine 61 precancerous cervical lesions 61 decompensated liver disease 61 multidrug resistant strains 61 gastrointestinal stromal tumors 61 carcinoid tumors 61 indolent NHL 61 imatinib resistance 61 sCJD 61 leukemia AML 61 metastatic RCC 61 ALI ARDS 61 multiple myeloma MM 61 SCIg 61 CIMZIA ™ 61 cytoreduction 61 Altastaph 61 S. aureus bacteremia 61 hepatitis B HBV 61 glioblastoma tumors 61 curable cancers 61 Chronic hepatitis B 61 recurrent glioblastoma 61 Cethromycin 61 malignant lymphomas 60 P. vivax malaria 60 HBeAg positive patients 60 PROCHYMAL 60 KRAS mutations occur 60 S. aureus infection 60 proteasome inhibitor 60 Chronic myeloid leukemia 60 relapsed ALL 60 co trimoxazole 60 postexposure prophylaxis 60 intracranial hemorrhage ICH 60 efalizumab 60 HPV genotypes 60 nonmelanoma skin cancer 60 T2DM 60 CDAD 60 basiliximab 60 refractory CLL 60 S. maltophilia 60 coinfected 60 Respiratory Syncytial Virus RSV 60 antiviral therapies 60 Epstein Barr virus EBV 60 hepatitis B infection 60 Zolinza 60 GISTs 60 trastuzumab Herceptin ® 60 Candida infections 60 hepatitis C virus 60 varicella infection 60 masitinib 60 meropenem 60 bladder cancers 60 Sebivo 60 acne vulgaris 60 malignant lymphoma 60 diarrhea CDAD 60 Chlamydia infections 60 immunodeficient 60 Sudhir Agrawal D.Phil 60 chronic granulomatous disease 60 transfusion transmitted 60 cidofovir 60 mRCC 60 multidrug resistance 60 lymphomas 60 malignant ascites 60 ovarian breast 60 EGFR blockers 60 cirrhosis liver failure 60 chemotherapy induced neutropenia 60 biologic DMARD 60 recurrent genital herpes 60 thalidomide Thalomid 60 uncomplicated malaria 60 chronic ITP patients 60 TEMODAL 60 pneumococcal infection 60 antithrombotic agents 60 monogenic 60 imipenem 60 symptomatic BPH 60 OncoVEX GM CSF 60 S aureus 60 delafloxacin 60 hepatocellular carcinomas 60 Polycythemia vera 60 receiving antiretroviral therapy 60 Onychomycosis 60 gonococcal infections 60 colorectal liver metastases 60 beta lactam antibiotic 60 Antiretroviral therapy 60 acute rhinosinusitis 60 LEUKINE 60 metastatic gastric 60 fluoroquinolone resistant 60 invasive cervical cancer 60 rhinovirus infections 60 viral hemorrhagic fevers 60 noninfectious uveitis 60 tipranavir ritonavir 60 nucleoside analogues 60 acute leukemias 60 pneumococci 60 AAT deficiency 60 Arcalyst 60 Crizotinib 60 Myelodysplastic syndromes MDS 60 basal cell cancers 60 Helicobacter pylori H. pylori 60 lipid lowering therapies 60 leukemia CLL 60 complete cytogenetic response 60 MGUS 60 ADPKD 60 Pulmonary arterial hypertension 60 H. pylori infection 60 recurrent glioblastoma multiforme 60 abnormal Pap smears 60 ROTARIX 60 doripenem 60 endocrine therapies 60 Tofacitinib 60 anti angiogenic therapy 60 falciparum malaria 60 TTR amyloidosis 60 WNV infection 60 Arranon 59 posterior uveitis 59 ELISPOT 59 basal cell carcinomas 59 chronic rhinosinusitis 59 macroalbuminuria 59 rectal gonorrhea 59 WNV encephalitis 59 sero positive 59 intra abdominal infections 59 Enterobacteriaceae 59 transthyretin amyloidosis 59 Vibrio infections 59 SNT-MC#/idebenone 59 HNSCC 59 seropositivity 59 AEG# 59 methylation markers 59 virus HBV 59 thyroid cancers 59 Chlamydia pneumoniae 59 HCV 59 latent tuberculosis infection 59 PAOD 59 GvHD 59 neurological manifestations 59 ductal cancer 59 AmBisome 59 chronically infected 59 cryptococcosis 59 posaconazole 59 breast carcinomas 59 chronic GVHD 59 Dacogen decitabine 59 Bloodstream infections 59 HBV vaccine 59 S.aureus 59 herpes labialis 59 P. knowlesi 59 HPV subtypes 59 metastatic melanomas 59 Medullary thyroid cancer 59 genital HSV 59 inhibitor RG# 59 alkylating agent 59 neuroendocrine tumors 59 cervical lesions 59 HCV protease inhibitors 59 Extensively drug 59 ZYVOX 59 Enterococcus faecium 59 protease inhibitors PIs 59 STELARA ™ 59 Evoltra ® 59 Renal cell carcinoma 59 CRBSIs 59 herpes infections 59 chronic HBV infections 59 C. diff infections 59 Panzem 59 pulmonary metastases 59 Raptiva ® 59 refractory gout 59 PTLD 59 G6PD deficiency 59 bexarotene 59 KETEK 59 non Hodgkin lymphomas 59 bendamustine 59 relapsed leukemia 59 nucleotide analog 59 SSc 59 SIR Spheres 59 ReA 59 Kepivance 59 oropharyngeal candidiasis 59 VaD 59 calcineurin inhibitors 59 rotavirus diarrhea 59 macrolide antibiotics 59 CIN3 + 59 severe rotavirus gastroenteritis 59 myeloproliferative diseases 59 leiomyomas 59 RSV infection 59 AA amyloidosis 59 metastatic lung cancer 59 null responder 59 HeFH 59 Zavesca R 59 methicillin susceptible Staphylococcus aureus 59 CIN3 59 severe sepsis 59 GABHS 59 grade cervical intraepithelial 59 FluCAM arm 59 myelofibrosis polycythemia vera 59 hepatocellular cancer 59 ACZ# 59 enteroviruses 59 diabetic nephropathy 59 ALT flares 59 HIV seropositive 59 histologic subtype 59 seronegative 59 pharmacologic intervention 59 esophageal candidiasis 59 SJIA 59 endophthalmitis 59 gonorrhoeae 59 seminoma 59 Chronic hepatitis C 59 Hib meningitis 59 bovine thrombin 59 ximelagatran 59 pancreatic adenocarcinoma 59 fluconazole resistant 59 cell lymphomas 59 Enterobacter cloacae 59 4CMenB 59 PARP inhibition 59 genital lesions 59 systemic scleroderma 59 lymphoma subtypes 59 chronic ITP 59 ESBLs 59 colorectal carcinomas 59 chronic periodontitis 59 oropharyngeal candidiasis OPC 59 pancreatic neuroendocrine tumors 59 antithrombotics 59 amoxicillin clavulanate 59 latent tuberculosis TB 59 atopic dermatitis 59 cytogenetic responses 59 Thiovir 59 voriconazole 59 cotrimoxazole 59 HIV1 59 Chronic sinusitis 59 TORISEL 59 osteoporotic fractures 59 Plasmodium falciparum malaria 59 imatinib Gleevec ® 59 Mucositis 59 cryptococcal meningitis 59 hepatitis B virus HBV 59 premalignant lesions 59 Human papillomavirus 59 resistant microorganisms 59 Telbivudine 59 nanoviricides 59 dapsone 59 hematological malignancy 59 combination antiretroviral therapy 59 beta interferons 59 Traficet EN 59 Leukemias 59 juvenile idiopathic arthritis JIA 59 TEAEs 59 OncoVex 59 rFVIIa 59 P aeruginosa 59 rheumatic diseases 59 extracolonic findings 59 paroxysmal AF 59 HBV vaccination 59 PCNSL 59 Relapsing remitting MS 59 Hurthle cell 59 Pemetrexed 59 HBV genotype 59 mTOR inhibitors 59 abnormal pap smears 59 dasatinib Sprycel 59 gemifloxacin 59 superficial basal cell carcinoma 59 eosinophilic pneumonia 59 NRTI resistance 59 BARACLUDE ® 59 ceftazidime 59 MRSA colonization 59 immunopathology 59 diabetic kidney 59 budesonide foam 59 lichen planus 59 HoFH 59 gonococcal infection 58 TNF alpha antagonist 58 metastatic renal cell 58 mediastinitis 58 Chronic Prostatitis 58 hematologic disorders 58 antiangiogenesis 58 Hereditary angioedema HAE 58 respiratory viral infections 58 lymphocytosis 58 hepatocellular carcinoma HCC 58 pneumococcal infections 58 Fabry Disease 58 Gastric cancer 58 Adhibit 58 HPV infections 58 G#DT 58 anogenital warts 58 TB MDR TB 58 pegylated interferons 58 metastatic colorectal 58 medulloblastomas 58 metastatic bladder 58 ketolide antibiotic 58 rotaviruses 58 MPS IVA 58 ertapenem 58 Hepatitis C virus HCV 58 generation cephalosporins 58 Glioblastoma Multiforme GBM 58 Helicobacter pylori 58 Gliomas 58 CP CPPS 58 external genital lesions 58 adenovirus infections 58 Doxil ® 58 Mycamine 58 CCR5 antagonist 58 HCV replicon 58 myeloproliferative neoplasms 58 chemoresistant 58 prostate cancer CaP 58 leukemia APL 58 S. aureus strains 58 mycobacterial infections 58 dopaminergic therapy 58 JAK inhibitors 58 pneumococcal strains 58 Vesivirus 58 bacterial vaginosis BV 58 serous ovarian cancer 58 Clostridium difficile associated 58 precursor lesions 58 neuroblastoma tumors 58 Hypotension 58 Onconase 58 HCV genotype 1 58 bacterium Neisseria meningitidis 58 HER2 overexpression 58 Severe Primary IGFD 58 Cryptococcus neoformans 58 LCMV infection 58 S. suis 58 GBM tumors 58 ofpatients 58 CMV infections 58 vivax 58 trabectedin 58 eosinophilic asthma 58 hemorrhagic cystitis 58 mtDNA mutations 58 Hib disease 58 Toxicities 58 artemisinins 58 MRSA isolates 58 hepatitis C viral infection 58 superinfection 58 curative therapy 58 adenocarcinomas 58 EGFR inhibitors 58 proctitis 58 squamous cell cancers 58 macrolide antibiotic 58 Azilect ® 58 oropharyngeal cancer 58 Candida species 58 Enbrel Humira 58 herpesviruses 58 orchitis 58 Aspergillus infections 58 thromboembolic disease 58 Torisel 58 multidrug resistant MDR 58 coagulation disorders 58 acute promyelocytic leukemia 58 chronic myeloid leukemia CML 58 BCR ABL inhibitors 58 endometrial hyperplasia 58 Aviptadil 58 infective endocarditis 58 bowel cancers 58 Golimumab 58 chronic hepatitis B 58 microscopic hematuria 58 Alinia 58 susceptible isolates 58 Glypromate 58 NovaBay Aganocide compounds 58 recurrent GBM 58 MenB 58 Aortic stenosis 58 Nonalcoholic fatty liver 58 pilocytic astrocytomas 58 Dasatinib 58 Azedra 58 cervical carcinoma 58 rheumatologic 58 Haptoglobin 58 FVIII inhibitors 58 ATL/TV# 58 multidrug resistant tuberculosis MDR 58 GnRH agonists 58 mupirocin 58 Chlamydia infection 58 HBeAg positive 58 lysosomal storage diseases 58 RAS blockers 58 pegylated interferon alpha 58 haematological malignancies 58 anal cancers 58 empyema 58 HIB vaccine 58 MPS VI 58 poliovirus vaccine 58 Tavocept 58 upper gastrointestinal bleeding 58 Epstein Barr Virus EBV 58 SSTIs 58 Gleevec imatinib mesylate 58 Human papilloma virus 58 opportunistic pathogens 58 HIV coinfected 58 liver scarring 58 multidrug resistant MDR TB 58 Opportunistic infections 58 KRAS status 58 postoperative atrial fibrillation 58 Chronic Myelogenous Leukemia CML 58 CCR5 tropic HIV 58 infections cIAI 58 streptococcal infections 58 cervical intraepithelial neoplasia 58 serogroup B 58 vaccinees 58 HSV1 58 bacterial overgrowth 58 arterial thrombosis 58 lumiliximab 58 Vandetanib 58 esophageal tumors 58 resistant isolates 58 mycophenolate mofetil MMF 58 bactericidal activity 58 pheochromocytoma 58 H. pylori eradication 58 astrocytomas 58 PREVENAR 58 efavirenz Sustiva 58 CLL SLL 58 virologic responses 58 zoster 58 hypervirulent strain 58 #I TM# 58 prostate adenocarcinoma 58 invasive pneumococcal disease 58 LHRH analogues 58 metastatic renal cell carcinoma 58 Myelodysplastic Syndrome MDS 58 serum antibody 58 BEXXAR 58 cranial irradiation 58 inhibit replication 58 anemias 58 bacteriuria 58 Menaflex implanted 58 heterosexually acquired 58 VUR 58 overactive bladder syndrome 58 TheraCIM 58 LQTS 58 CIN2 + 58 Paromomycin 58 hypereosinophilic syndrome 58 hepatocellular carcinoma 58 zidovudine AZT 58 leukemias lymphomas 58 Bacillus Calmette Guerin BCG 58 mycobacterium tuberculosis 58 Non Hodgkin lymphomas 58 lipid abnormalities 58 Fludara ® 58 gastrointestinal stromal tumors GISTs 58 receptor tyrosine kinase inhibitor 58 paromomycin 57 recurrent glioma 57 thrombotic complications 57 mutated KRAS gene 57 kidney urologic 57 osteoporotic vertebral fractures 57 childhood leukemias 57 antimicrobial prophylaxis 57 antiviral prophylaxis 57 atherothrombosis 57 Irinotecan 57 Actimmune ® 57 chromosomal rearrangement 57 ELISpot 57 SEBIVO 57 serogroups 57 ErbB2 positive 57 EXJADE 57 prednisone prednisolone 57 RhuDex ® 57 mycophenolate mofetil 57 seropositive patients 57 ZADAXIN ® 57 Ebola virus infection 57 EBV infection 57 MYCN amplification 57 immunodeficiency disorders 57 hepatitis viruses 57 ATTR CM 57 helicobacter pylori 57 ALK inhibitors 57 nucleotide analogue 57 relapsed ovarian cancer 57 Urinary tract infections UTIs 57 pegylated interferon alfa 57 HepaGam B TM 57 Thyroid nodules 57 dengue hemorrhagic fever DHF 57 carbapenem resistant 57 WNV infections 57 Noxafil 57 HuLuc# 57 M#V mutation 57 hepatic liver 57 Imatinib 57 prevalent sexually transmitted 57 mutated K ras 57 nasopharyngeal cancer 57 VIDAZA 57 gastrointestinal stromal tumors GIST 57 ribavirin therapy 57 idiopathic pulmonary fibrosis IPF 57 coinfection 57 GRN# 57 prophylactic vaccines 57 pancreatic insufficiency 57 cholangiocarcinoma 57 psoriatic arthritis PsA 57 pyelonephritis 57 VZV 57 systemic lupus erythematosus SLE 57 ceftriaxone 57 follicular lymphoma FL 57 gonococcal 57 SUTENT 57 GBMs 57 NGAL 57 nonvaccine 57 myeloproliferative disorders 57 methicillin resistant S. aureus 57 Proleukin 57 adalimumab Humira 57 eprotirome 57 Helicobacter pylori infection 57 atherothrombotic events 57 Fanconi syndrome 57 Privigen 57 fidaxomicin 57 praziquantel 57 urethritis 57 bacterial vaginosis 57 TTR gene 57 miltefosine 57 TMP SMX 57 idiopathic thrombocytopenic purpura ITP 57 neurologic complications 57 fluoroquinolone antibiotic 57 erlotinib Tarceva ® 57 TYGACIL 57 benign prostatic hypertrophy BPH 57 BRCA1 mutation carriers 57 nonalcoholic steatohepatitis NASH 57 interstitial pneumonia 57 EGFR mutation 57 secondary hyperparathyroidism 57 HBV genotypes 57 Diabetic Peripheral Neuropathy 57 renal toxicity 57 pan HDAC inhibitor 57 Hepatitis C Virus 57 Methicillin 57 adjuvant therapies 57 delayed CINV 57 infectious syphilis 57 anagrelide 57 novel VDA molecule 57 Neulasta ® 57 underdiagnosis 57 hepatitis B immunoglobulin 57 oesophageal adenocarcinoma 57 ophthalmic diseases 57 metastatic prostate 57 antiandrogens 57 hyperphenylalaninemia HPA due 57 Navelbine ® 57 recurrent venous thromboembolism 57 diarrhea predominant irritable 57 achieved sustained virological 57 gastric carcinoma 57 B CLL 57 T. pallidum 57 Nimotuzumab 57 Acute Myeloid Leukaemia AML 57 Acute myeloid leukemia 57 intestinal metaplasia 57 corticosteroid therapy 57 metastatic malignant melanoma 57 alkylating agents 57 quinolone 57 Afatinib 57 cytomegalovirus CMV 57 Tesmilifene 57 unresectable tumors 57 Allovectin 7 ® 57 immunomodulatory therapy 57 precancers 57 HPV-#/# 57 β blockers 57 Bezielle 57 linezolid resistant 57 idiopathic myelofibrosis 57 chronic hepatitis C. 57 Waldenstrom macroglobulinemia 57 ganciclovir 57 severe malignant osteopetrosis 57 Civacir 57 hyper virulent strain 57 BRAF V# mutation 57 evaluable subjects 57 BCG refractory 57 taxane resistant 57 cervical HPV 57 Myelodysplastic syndromes 57 YONDELIS 57 homozygous FH 57 varicella zoster virus VZV 57 Severe VOD 57 CEQ# 57 Hepatitis B virus 57 MabThera Rituxan 57 microbiological eradication 57 HIVAN 57 Aloxi injection 57 neovascular diseases 57 virus XMRV 57 inflammatory bowel diseases 57 GBA mutations 57 castrate resistant 57 beta thalassemia 57 velafermin 57 Aflibercept 57 MRSA strains 57 onset atrial fibrillation 57 LHRH agonists 57 erythromycin resistant 57 underwent resection 57 viral kinetics 57 antiplatelet therapies 57 CMV reactivation 57 methicillin resistant 57 common hematologic malignancy 57 dengue haemorrhagic fever DHF 57 MYCAMINE 57 campylobacter infections 57 Vectibix monotherapy 57 pexiganan 57 HuMax CD4 57 Clevudine 57 lenalidomide dexamethasone 57 intracranial aneurysms 57 malignancies 57 Glioblastoma Multiforme 57 Etravirine 57 cediranib 57 glucocorticoid induced osteoporosis 57 Tamibarotene 57 Schistosomiasis 57 Eltrombopag 57 benign neoplasms 57 Nexavar sorafenib 57 Celiac disease affects 57 Basal cell 57 congenital CMV 57 vidofludimus 57 myeloproliferative 57 OMP #M# 57 tubercle bacillus 57 etanercept Enbrel 57 pituitary adenomas 57 Pneumococcal pneumonia 57 HbF 57 refractory Hodgkin 57 Acute Myocardial Infarction AMI 57 deferiprone 57 deletion 5q 57 falciparum 57 HPV# 57 chronic HCV genotype 57 Cimzia TM 57 Lung transplantation 57 Hepatitis B virus HBV 57 carcinoids 57 invasive Hib 57 Virulizin ® 57 hormone refractory 57 atrophic gastritis 57 chlamydia infections 57 LHRH antagonists 57 Telintra 57 Human papillomavirus HPV 57 Papillary 57 adenomatous polyps 57 IDH1 mutation 57 HGPIN 57 invasive MRSA infections 57 FluCide 57 haematological cancers 57 Mipomersen 57 Plaque psoriasis 57 rheumatic disease 57 peritoneal cancer 57 breast abscesses 57 hemagglutination inhibition 57 Nilotinib 57 hematologic abnormalities 57 intravesical therapy 57 liver metastases 57 Basal cell carcinoma 57 Surgical resection 57 Thyroid cancer 57 TREANDA 57 vancomycin resistant 57 leukemia CML 57 SSc patients 57 lupus nephritis 57 serologically 57 debilitating autoimmune 57 antiangiogenic therapy 57 HIF PHI 57 plasma kallikrein 57 anticoagulant warfarin 57 pneumococcal pneumonia 57 T#I [002] 57 chlorambucil 57 squamous cell carcinoma SCC 57 ESBL producing E. coli 57 HCV genotype 57 abacavir Ziagen 57 tipranavir 57 probiotic supplementation 57 bacterial sepsis 57 protease inhibitor PI 57 ORENCIA ® 57 sporadic Creutzfeldt Jakob 57 necrotizing pneumonia 57 IGFD 57 Cancidas 57 sputum microscopy 57 Legg Calvé Perthes disease 57 S. aureus bacteria 57 relapsed multiple myeloma 57 Entamoeba histolytica 57 bacterium Mycobacterium tuberculosis 57 Apaziquone 57 Moxifloxacin 57 coinfected patients 57 miglustat 57 hereditary predisposition 57 autoantibody positive 57 rhinosinusitis 57 renal transplants 57 hamartomas 57 Juvenile Idiopathic Arthritis JIA 57 ductal carcinomas 57 PNH patients 57 prolonged QT interval 57 definite stent thrombosis 57 Ribavirin causes 57 primaquine 57 ImmunoVEX HSV2 57 pre malignant lesions 57 solithromycin 57 diagnostic modality